SCHEMBL8119974

SCHEMBL8119974

CCCCCC(CC(=O)Nc1cc(C(=O)NC(C)=O)ccc1C(C)(C)C)c1ccc(OC)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 1/20 0.39
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HDAC1 Q13547 2/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
KMT2A Q03164 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC2 Q92769 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HTT P42858 1/20 0.34
MEN1 O00255 1/20 0.34
PLK1 P53350 1/20 0.34
PLK3 Q9H4B4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8131422 0.99 LPAR1 (0.39) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8121334 0.97 LPAR1 (0.40) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8120544 0.93 KMT2A (0.40) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8148216 0.93 LPAR1 (0.41) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8136536 0.93 LPAR1 (0.39) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8121220 0.93 LPAR1 (0.39) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8123377 0.93 LPAR1 (0.39) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8134646 0.93 LPAR1 (0.40) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8120317 0.92 GAA (0.39) LPAR1MAPK1ALDH1A1MAPTTSHR
SCHEMBL8128616 0.91 LPAR1 (0.40) LPAR1MAPK1ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP claimed
US-6040339-A TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL SANKYO COMPANY, LIMITED (JP) 2000-03-21 US claimed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP claimed
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP disclosed
US-6040339-A TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL SANKYO COMPANY, LIMITED (JP) 2000-03-21 US disclosed
US-5880147-A Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use SANKYO COMPANY, LIMITED (JP) 1999-03-09 US disclosed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP disclosed